
CJC-1295 DAC
Cββ βHββ βNββOββ
Modified GRF analog with Drug Affinity Complex for extended half-life GH research applications.
Select Size
Quantity
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been modified with a DAC moiety to extend its half-life. The DAC component binds to albumin in the bloodstream, resulting in a significantly prolonged duration of action compared to unmodified GRF analogs. Research has focused on its ability to sustain elevated GH and IGF-1 levels over extended periods, making it valuable for studying long-term GH-axis modulation.
Related Compounds
Research Use Only β Legal Disclaimer
All products sold by Halo Peptides are strictly intended for in-vitro research, laboratory use, and scientific investigation only. They are not intended for human consumption, veterinary use, diagnostic purposes, or any therapeutic application. By browsing this website and purchasing any product, you acknowledge and agree that you are a qualified researcher and will use all compounds in compliance with applicable local, national, and international laws and regulations.



